In the European Union,<unk>  is indicated as monotherapy in adults for the treatment of polycythemia vera without symptomatic splenomegaly. In the United States it is indicated for the treatment of polycythemia vera.
Ropeginterferon alfa-2b
Peginterferon alfa-2a
Peginterferon alfa-2b
Peginterferon beta-1a
Pegylated interferon
Ribavirin
Taribavirin
Telbivudine